The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.
about
Chronic Hepatitis B with Spontaneous Severe Acute ExacerbationThe Role of Oxidative Stress and Antioxidants in Liver DiseasesDoes antiviral therapy reduce complications of cirrhosis?The efficacy and safety of Nucleos(t)ide analogues in patients with spontaneous acute exacerbation of chronic hepatitis B: a systematic review and meta-analysisSerum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver FailureAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbationOn-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational studyAntiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.Lamivudine for chronic hepatitis B.Predictors of the outcomes of acute-on-chronic hepatitis B liver failure.Predicting survival in hepatitis B.Personal view: the management of chronic hepatitis B infection.Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failureAnti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure.Entecavir and lamivudine therapy for severe acute chronic hepatitis B.Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.Management of hepatitis B virus-related acute liver failure.Icteric flare of chronic hepatitis B in a 95-year old patient.Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.Autoimmune fulminant liver failure in adults: Experience in a Japanese center.Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection.Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.
P2860
Q26772036-190E0320-3F2A-4C1B-9F07-7CCEF169770CQ26779146-1006DF97-7680-41A8-8765-1323C14EFAACQ26851410-C88D7AF4-EB46-4A60-B28C-B612C32C86D1Q28533788-1E103777-847F-4E39-8005-4BF2405EF594Q30358956-A9AE23C8-9AF2-44EA-AEA5-30068D3E799FQ30391932-7467CD98-7A0F-44EC-8CB0-ED02B876B1D2Q33623019-38613851-87DE-488A-9A33-BDA0BFDCBB6BQ34552034-4C8A9F84-2935-4B7D-A87E-098E297B0523Q34553545-87750F0D-A081-42C2-8AC5-FFC70D1CED21Q34978162-36227808-5271-4541-AF93-DB0D4EFE8F9FQ35840984-2FCF7DFE-6A95-48D8-B5B5-38C8A3A519DAQ35917357-147ADE1E-4397-422C-9DD0-E5463C6595F1Q36285798-85336047-BEED-4A69-911F-5AAE61353809Q36287594-8379C305-D788-4EAD-8356-22D8FF06D69DQ36435893-92AB8020-DC22-4BFD-9DBA-C49E64EA29C4Q36637720-6D400857-8D48-40BB-9DBA-2518DBC88945Q38383397-25821254-1DCC-45D9-A658-FCD9ED40518BQ40441364-59B4B0AD-04F4-46E1-9428-10005B80B78FQ41201870-AF450104-01A0-48DE-9FEE-8FD08C6116E0Q42110843-81664C98-01EF-4098-9BFF-81C4A32716A1Q42223335-D120A257-96C0-4FF6-8239-36DF86AAAB57Q42240045-435D5131-CF69-4158-B525-2785A366225DQ42243094-42AD7789-85B4-4B4B-992F-F26B30528EC8Q42588869-587D79EC-BD68-44A0-9B9B-45BF6824B7E2Q43227919-71B7B679-4873-4AD4-B5DF-C165CB1B5E7FQ44043595-A453C726-522F-458C-9F02-7A0B4445F351Q44135447-1877C9AB-D12D-4395-8E47-B73D306CC170Q45015757-3B4361D3-F3C2-4751-8214-C02A50DBD9ACQ45163314-B87EAE19-5576-4D2B-A9F4-3B92FA03F4B9Q45341253-904AED2D-08F0-41C4-92B9-043836F20422
P2860
The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@ast
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@en
type
label
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@ast
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@en
prefLabel
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@ast
The role of lamivudine and pre ...... nic hepatitis B with jaundice.
@en
P2093
P2860
P1476
The role of lamivudine and pre ...... onic hepatitis B with jaundice
@en
P2093
P2860
P304
P356
10.1046/J.1365-2893.2002.00385.X
P577
2002-11-01T00:00:00Z